person · Reporting owner

Kliman Gilbert H

Disclosed activity across 9 companies

Tapewire entity: 21207
SEC CIK: 0001293171

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Braze, Inc.BRZE · Entity 4102	10% owner	February 08, 2022	February 09, 2022
GLAUKOS CorpGKOS · Entity 3510	Director	August 19, 2026	August 21, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Braze, Inc.

Report date February 08, 2022 · Filed February 09, 2022

Jointly reported with InterWest Management Partners X, LLC, INTERWEST PARTNERS X LP, NASR KHALED, Desai Keval

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy: InterWest Partners X, LP	3,394,219	Reported balance After 2022-02-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-02-08 · Conversion · Acquired 3,394,219 · Balance 3,394,219 F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy: InterWest Partners X, LP	0	Reported balance After 2022-02-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-02-08 · Conversion · Disposed 3,394,219 · Balance 0 F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.

F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock.

GLAUKOS Corp

Report date August 19, 2026 · Filed August 21, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	37,406	Last balance in matching sequence After 2026-08-19 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-08-19 · Exercise / conversion · Acquired 2,500 · Balance 39,906 F1: Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Row 2 · 2026-08-19 · Sale · Disposed 2,500 · Balance 37,406 F1: Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.77 · Expires 2027-12-13	Direct	12,500	Reported balance After 2026-08-19 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-08-19 · Exercise / conversion · Disposed 2,500 · Balance 12,500

Filing footnotes · ownership attribution and instrument terms

F1: Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.

Past disclosures · reporting ended (7)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AVEDRO INC

Report date November 21, 2019 · Filed November 25, 2019

Jointly reported with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, ORONSKY ARNOLD L, NASR KHALED, Desai Keval

Section 16 reporting ended · disclosed 2019-11-25. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-11-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-11-21 · Other · Disposed 2,742,239 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share. F2: The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	0	Reported balance After 2019-11-21 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2019-11-21 · Other · Disposed 3,005 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share. F3: The securities are directly held by InterWest Venture Management Company ("IVMC"). Gilbert H. Kliman transferred these shares to IVMC for no consideration pursuant to a contractual agreement between Kliman and IW10. Arnold L. Oronsky and Gilbert H. Kliman are owners, directors and officers of IVMC and as such may be deemed to beneficially own the shares held by IVMC. Each of Arnold L. Oronsky and Gilbert H. Kliman disclaim beneficial ownership of such shares except to the extend of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share.

F2: The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F3: The securities are directly held by InterWest Venture Management Company ("IVMC"). Gilbert H. Kliman transferred these shares to IVMC for no consideration pursuant to a contractual agreement between Kliman and IW10. Arnold L. Oronsky and Gilbert H. Kliman are owners, directors and officers of IVMC and as such may be deemed to beneficially own the shares held by IVMC. Each of Arnold L. Oronsky and Gilbert H. Kliman disclaim beneficial ownership of such shares except to the extend of his pecuniary interest therein.

Doximity, Inc.

Report date August 02, 2022 · Filed August 05, 2022

Section 16 reporting ended · disclosed 2022-08-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	449,960	Reported balance After 2022-08-02 transaction · row 1 1 source row Row 1 · 2022-08-02 · Disposition to issuer · Disposed 4,714 · Balance 449,960 F1: Termination of restricted stock units, originally granted on July 27, 2022 pursuant to the Issuer's non-employee director compensation policy, due to Reporting Person's resignation from the Board of Directors on 8/2/2022.

Filing footnotes · ownership attribution and instrument terms

F1: Termination of restricted stock units, originally granted on July 27, 2022 pursuant to the Issuer's non-employee director compensation policy, due to Reporting Person's resignation from the Board of Directors on 8/2/2022.

Eiger BioPharmaceuticals, Inc.

Report date October 18, 2018 · Filed October 22, 2018

Jointly reported with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, ORONSKY ARNOLD L, Desai Keval, NASR KHALED

Section 16 reporting ended · disclosed 2018-10-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,362,327	Last balance in matching sequence After 2018-10-18 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2018-10-18 · Sale · Disposed 210,800 · Balance 1,388,792 F1: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.30 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement. Row 2 · 2018-10-18 · Sale · Disposed 26,465 · Balance 1,362,327 F2: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.03 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Filing footnotes · ownership attribution and instrument terms

F1: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.30 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.03 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

PMV Pharmaceuticals, Inc.

Report date July 13, 2021 · Filed July 14, 2021

Jointly reported with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, NASR KHALED, Desai Keval

Section 16 reporting ended · disclosed 2021-07-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,469,911	Reported balance After 2021-07-13 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-07-13 · Other · Disposed 500,000 · Balance 4,469,911 F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.
Common StockSEC Table I · non-derivative	IndirectBy: InterWest Management Partners X, LLC	0	Last balance in matching sequence After 2021-07-13 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 2 · 2021-07-13 · Other · Acquired 97,632 · Balance 97,632 F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Row 3 · 2021-07-13 · Other · Disposed 97,632 · Balance 0 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy: Khaled A. Nasr	4,201	Reported balance After 2021-07-13 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2021-07-13 · Other · Acquired 3,642 · Balance 4,201 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy: Keval Desai	2,816	Reported balance After 2021-07-13 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-07-13 · Other · Acquired 2,441 · Balance 2,816 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy Gilbert H. Kliman	25,552	Reported balance After 2021-07-13 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-07-13 · Other · Acquired 22,148 · Balance 25,552 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.

F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman").

F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.

STAAR SURGICAL CO

Report date December 01, 2023 · Filed December 05, 2023

Section 16 reporting ended · disclosed 2023-12-05. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Venus Concept Inc.

Report date November 07, 2019 · Filed November 13, 2019

Section 16 reporting ended · disclosed 2019-11-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	658,657	Reported balance After 2019-11-07 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2019-11-07 · Conversion · Acquired 301,605 · Balance 658,657 F1: Received in connection with the Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer (formerly known as Restoration Robotics, Inc.), Radiant Merger Sub Ltd, an entity organized under the laws of Israel and Venus Concept Ltd, an entity organized under the laws of Israel (the "Merger"), upon the conversion of the outstanding principal and any accrued and unpaid interest of an 8% Convertible Promissory Notes issued by Venus Concept Inc., dated as of February 28, 2019 in the original principal amount of $2,000,000.00 and accrued interest income of $110,027.40. Share data reported herein reflects the 1-for-15 reverse stock split that occurred after the note conversion on November 7, 2019. F3: This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664 prior to the 1-for-15 reverse stock split that occurred on November 7, 2019. F2: The securities are directly held by InterWest Partners IX, LP ("IW9"). InterWest Management Partners IX, LLC ("IMP9") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. The Reporting Person is a Managing Director of IMP9, and as such may be deemed to beneficially own the shares held by IW9. The Reporting Person disclaims beneficial ownership of such shares except to the extend of his pecuniary interest therein. The Reporting Person ceased to be a Director of the Issuer, and IW9 ceased to be a 10% owner of the Issuer, upon closing of the Merger.
Unsecured Subordinated Convertible Promissory NoteSEC Table II · derivative / convertible security · Expires 2020-08-28	IndirectSee footnote	0	Reported balance After 2019-11-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-11-07 · Conversion · Disposed Not disclosed · Balance 0 F3: This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664 prior to the 1-for-15 reverse stock split that occurred on November 7, 2019. F4: This Unsecured Subordinated Convertible Promissory Note converted upon the consummation of the Merger, pursuant to its terms. F2: The securities are directly held by InterWest Partners IX, LP ("IW9"). InterWest Management Partners IX, LLC ("IMP9") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. The Reporting Person is a Managing Director of IMP9, and as such may be deemed to beneficially own the shares held by IW9. The Reporting Person disclaims beneficial ownership of such shares except to the extend of his pecuniary interest therein. The Reporting Person ceased to be a Director of the Issuer, and IW9 ceased to be a 10% owner of the Issuer, upon closing of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Received in connection with the Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer (formerly known as Restoration Robotics, Inc.), Radiant Merger Sub Ltd, an entity organized under the laws of Israel and Venus Concept Ltd, an entity organized under the laws of Israel (the "Merger"), upon the conversion of the outstanding principal and any accrued and unpaid interest of an 8% Convertible Promissory Notes issued by Venus Concept Inc., dated as of February 28, 2019 in the original principal amount of $2,000,000.00 and accrued interest income of $110,027.40. Share data reported herein reflects the 1-for-15 reverse stock split that occurred after the note conversion on November 7, 2019.

F2: The securities are directly held by InterWest Partners IX, LP ("IW9"). InterWest Management Partners IX, LLC ("IMP9") as the general partner of IW9, may be deemed to beneficially own the shares held by IW9. The Reporting Person is a Managing Director of IMP9, and as such may be deemed to beneficially own the shares held by IW9. The Reporting Person disclaims beneficial ownership of such shares except to the extend of his pecuniary interest therein. The Reporting Person ceased to be a Director of the Issuer, and IW9 ceased to be a 10% owner of the Issuer, upon closing of the Merger.

F3: This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664 prior to the 1-for-15 reverse stock split that occurred on November 7, 2019.

F4: This Unsecured Subordinated Convertible Promissory Note converted upon the consummation of the Merger, pursuant to its terms.

Vyome Holdings, Inc

Report date August 06, 2019 · Filed August 08, 2019

Jointly reported with INTERWEST PARTNERS X LP, InterWest Management Partners X, LLC, ORONSKY ARNOLD L, Desai Keval, NASR KHALED

Section 16 reporting ended · disclosed 2019-08-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	380,224	Reported balance After 2019-08-06 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-08-06 · Purchase · Acquired 25,000 · Balance 380,224 F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants. F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.
Warrants (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.40 · Expires 2024-08-05	Direct	18,750	Reported balance After 2019-08-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-08-06 · Purchase · Acquired 18,750 · Balance 18,750 F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants. F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants.

F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 19, 2022 Filed Aug 19, 2022 20:00 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	2,382	$0.00	$0.00	Disclosure SEC source: 0000899243-22-029268 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,923 F1 · kind: The Reporting Person transferred these shares to InterWest Venture Management Company ("IVMC") for no consideration, pursuant to an agreement between the Reporting Person and InterWest Partners X, LP ("IP10") relating to compensation received in connection with his service as director of the Issuer. F3 · balance_after: Includes 4,364 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document
August 05, 2022 Filed Aug 8, 2022 20:59 UTC	GLAUKOS Corp GKOS · Entity 3510	SaleCommon Stock	3,362	$53.01	$178,229.37	Disclosure SEC source: 0000899243-22-028000 · doc4.xml · nonDerivative · entry 5 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners IX, LP Disclosed balance after: 0 F4 · price: The price represents the weighted-average price of the shares sold in multiple transactions ranging from $52.77 to $53.165 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Consists of shares owned by InterWest Partners IX, LP ("IP9"). The Reporting Person is a Managing Director of InterWest Management Partners IX, LLC, the general partner of IP9. The Reporting Person has shared voting and investment control over shares owned by IP9, and disclaims beneficial ownership of those securities, except to the extent of his pecuniary interest therein. Read SEC document
August 04, 2022 Filed Aug 8, 2022 20:59 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	19,045	$0.00	$0.00	Disclosure SEC source: 0000899243-22-028000 · doc4.xml · nonDerivative · entry 4 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,305 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 19,045 shares distributed to the Reporting Person. F7 · balance_after: Includes 6,746 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document
August 04, 2022 Filed Aug 8, 2022 20:59 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	83,955	$0.00	$0.00	Disclosure SEC source: 0000899243-22-028000 · doc4.xml · nonDerivative · entry 3 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · InterWest Management Partners X, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 19,045 shares distributed to the Reporting Person. F3 · ownership.nature: The shares are owned by IP10. The general partner of IP10 is IMP10. The Reporting Person has shared voting and investment control over shares owned by IP10, and disclaims beneficial ownership of those securities, except to the extent of his pecuniary interest therein. Read SEC document
August 04, 2022 Filed Aug 8, 2022 20:59 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	83,955	$0.00	$0.00	Disclosure SEC source: 0000899243-22-028000 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · InterWest Management Partners X, LLC Disclosed balance after: 83,955 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IP10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 83,955 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are owned by IP10. The general partner of IP10 is IMP10. The Reporting Person has shared voting and investment control over shares owned by IP10, and disclaims beneficial ownership of those securities, except to the extent of his pecuniary interest therein. Read SEC document
August 04, 2022 Filed Aug 8, 2022 20:59 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	333,917	$0.00	$0.00	Disclosure SEC source: 0000899243-22-028000 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · InterWest Partners X, LP Disclosed balance after: 0 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IP10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 83,955 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are owned by IP10. The general partner of IP10 is IMP10. The Reporting Person has shared voting and investment control over shares owned by IP10, and disclaims beneficial ownership of those securities, except to the extent of his pecuniary interest therein. Read SEC document
August 02, 2022 Filed Aug 5, 2022 21:32 UTC	Doximity, Inc. DOCS · Entity 1570	Disposition to issuerClass A Common Stock	4,714	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-027860 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,960 F1 · price: Termination of restricted stock units, originally granted on July 27, 2022 pursuant to the Issuer's non-employee director compensation policy, due to Reporting Person's resignation from the Board of Directors on 8/2/2022. Read SEC document
July 27, 2022 Filed Jul 29, 2022 20:29 UTC	Doximity, Inc. DOCS · Entity 1570	GrantClass A Common Stock	4,714	$0.00	$0.00	Disclosure SEC source: 0001516513-22-000062 · wf-form4_165912657505254.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,674 F1 · shares: Represents restricted stock units granted on July 27, 2022 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document
June 16, 2022 Filed Jun 17, 2022 22:40 UTC	STAAR SURGICAL CO STAA · Entity 4851	Exercise / conversionCommon Stock	2,899	$0.00	$0.00	Disclosure SEC source: 0001209191-22-038104 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The restrictions on the 2899 restricted shares of common stock awarded on his re-election to the Board of Directors lapse on the earlier of June 16, 2023 or the Corporation's 2023 Annual Meeting, subject to his continued service through that date. Read SEC document
June 16, 2022 Filed Jun 17, 2022 22:40 UTC	STAAR SURGICAL CO STAA · Entity 4851	Exercise / conversionCommon Stock	355	$0.00	$0.00	Disclosure SEC source: 0001209191-22-038104 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document
June 02, 2022 Filed Jun 6, 2022 23:51 UTC	GLAUKOS Corp GKOS · Entity 3510	GrantCommon Stock	4,364	$0.00	$0.00	Disclosure SEC source: 0001104659-22-068662 · tm2217841-1_4seq1.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,260 F1 · security: Represents a grant of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 6,746 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document
May 18, 2022 Filed May 18, 2022 23:06 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	980	$0.00	$0.00	Disclosure SEC source: 0000899243-22-018663 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Venture Management Co. Disclosed balance after: 13,965 F1 · kind: The Reporting Person transferred these shares to InterWest Venture Management Company ("IVMC") for no consideration, pursuant to an agreement between the Reporting Person and InterWest Partners X, LP ("IP10") relating to compensation received in connection with his service as director of the Issuer. F2 · ownership.nature: The shares are owned by IVMC. The Reporting Person is an officer, director and the sole shareholder of IVMC and has sole voting and investment control over the shares held by IVMC. Read SEC document
May 18, 2022 Filed May 18, 2022 23:06 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	980	$0.00	$0.00	Disclosure SEC source: 0000899243-22-018663 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,896 F1 · kind: The Reporting Person transferred these shares to InterWest Venture Management Company ("IVMC") for no consideration, pursuant to an agreement between the Reporting Person and InterWest Partners X, LP ("IP10") relating to compensation received in connection with his service as director of the Issuer. F5 · balance_after: Includes 2,382 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document
February 25, 2022 Filed Feb 25, 2022 21:46 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	826	$59.00	$48,734.00	Disclosure SEC source: 0000899243-22-007892 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,960 Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:46 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	29,174	$56.09	$1,636,395.92	Disclosure SEC source: 0000899243-22-007892 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,786 F1 · price: The price represents the weighted-average price of the shares sold in multiple transactions ranging from $55.50 to $56.48 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 08, 2022 Filed Feb 9, 2022 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass B Common Stock · Derivative	3,394,219	$0.00	$0.00	Disclosure SEC source: 0000899243-22-005442 · doc4.xml · derivative · entry 2 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Partners X, LP Disclosed balance after: 0 Underlying: Class A Common Stock · 3,394,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
February 08, 2022 Filed Feb 9, 2022 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass A Common Stock	3,394,219	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-005442 · doc4.xml · nonDerivative · entry 1 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Partners X, LP Disclosed balance after: 3,394,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
December 07, 2021 Filed Dec 9, 2021 02:00 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	5,980	$62.00	$370,760.00	Disclosure SEC source: 0000899243-21-047428 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,960 Read SEC document
December 07, 2021 Filed Dec 9, 2021 02:00 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	8,912	$63.00	$561,456.00	Disclosure SEC source: 0000899243-21-047428 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,940 Read SEC document
December 03, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	2,000	$65.82	$131,649.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 6 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,852 F6 · price: The price represents the weighted-average price of the shares sold in multiple transactions ranging from $64.10 to $66.27 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · derivative · entry 7 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 8,556,998 Underlying: Class A Common Stock · 4,300,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	249,778	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 5 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,852 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 249,778 shares distributed to Gilbert H. Kliman ("Kliman"). Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,101,094	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 4 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 249,778 shares distributed to Gilbert H. Kliman ("Kliman"). F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,101,094	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 3 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 1,101,094 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 7, 2021 01:05 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass A Common Stock	4,300,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-047010 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass B Common Stock · Derivative	1,130,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 9 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 3,394,219 Underlying: Class A Common Stock · 1,130,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	OtherClass B Common Stock · Derivative	4,524,219	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 8 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,524,219 Underlying: Class A Common Stock · 4,524,219 shares Expires not disclosed F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F3 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries D Preferred Stock · Derivative	95,976	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 7 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 95,976 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries C Preferred Stock · Derivative	1,603,848	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 6 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,603,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries B Preferred Stock · Derivative	2,824,395	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 5 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 2,824,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	SaleClass A Common Stock	1,130,000	$61.42	$69,404,600.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 4 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass A Common Stock	1,130,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 3 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 1,130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	OtherCommon Stock	4,524,219	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 2 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F3 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionCommon Stock	4,524,219	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 1 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,524,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · derivative · entry 6 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 12,856,998 Underlying: Class A Common Stock · 4,300,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	247,074	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · nonDerivative · entry 5 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,074 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 247,074 shares distributed to Gilbert H. Kliman ("Kliman"). Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,089,179	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · nonDerivative · entry 4 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 247,074 shares distributed to Gilbert H. Kliman ("Kliman"). F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,089,179	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · nonDerivative · entry 3 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 1,089,179 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,089,179 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,089,179 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:38 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass A Common Stock	4,300,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-044592 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4 · ownership.nature: These shares are directly held by IW10. IMP10, as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. The Reporting Person is the Managing Director of IMP10, and as such may be deemed to beneficially own the shares held by IW10. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document
September 08, 2021 Filed Sep 10, 2021 20:16 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	3,900	$0.00	$0.00	Disclosure SEC source: 0001104659-21-114673 · tm2127285-1_4seq1.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Venture Management Company Disclosed balance after: 12,985 F1 · kind: The Reporting Person transferred these shares to InterWest Venture Management Company ("IVMC"), for no consideration, pursuant to an agreement between the Reporting Person and InterWest Partners X, LP ("IP10") relating to compensation received in connection with his service as a director of the Issuer. F3 · ownership.nature: Consists of shares owned by IVMC. The Reporting Person is an officer, director and the sole shareholder of IVMC and has sole voting and investment control over the shares held by IVMC. Read SEC document
September 08, 2021 Filed Sep 10, 2021 20:16 UTC	GLAUKOS Corp GKOS · Entity 3510	OtherCommon Stock	3,900	$0.00	$0.00	Disclosure SEC source: 0001104659-21-114673 · tm2127285-1_4seq1.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,876 F1 · kind: The Reporting Person transferred these shares to InterWest Venture Management Company ("IVMC"), for no consideration, pursuant to an agreement between the Reporting Person and InterWest Partners X, LP ("IP10") relating to compensation received in connection with his service as a director of the Issuer. F2 · balance_after: Includes 3,362 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	22,148	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert H. Kliman Disclosed balance after: 25,552 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	2,441	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 2,816 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	3,642	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 4,201 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	97,632	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	97,632	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 97,632 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	500,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,469,911 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document
June 28, 2021 Filed Jun 28, 2021 22:16 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,289,250	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013074 · wf-form4_162491854483661.xml · derivative · entry 7 Kliman Gilbert H · CIK 0001293171 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 17,156,998 Underlying: Class A Common Stock · 4,289,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.nature: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X"), as the general partner of InterWest, may be deemed to beneficially own the shares held by InterWest. The Reporting Person is the Managing Director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.